Interleukin-1 alpha in blood has direct access to cortical brain cells

W A Banks1, A J Kastin, E G Gutierrez

  • 1Veterans Affairs Medical Center, New Orleans, LA 70146.

Neuroscience Letters
|November 26, 1993
PubMed

Insights

Circulating Interleukin-1 alpha (IL-1 alpha) directly enters the brain

Area of Science:

  • Neuroscience
  • Immunology
  • Physiology

Background:

  • Interleukin-1 alpha (IL-1 alpha) is an immune protein affecting the central nervous system (CNS).
  • The blood-brain barrier (BBB) typically restricts protein entry into the brain and cerebrospinal fluid (CSF).

Purpose of the Study:

  • To investigate the direct entry mechanism of IL-1 alpha into the CNS across the BBB.
  • To determine if IL-1 alpha can cross the BBB intact and influence brain function.

Main Methods:

  • Used selective interleukin receptor antagonist (IL-1ra).
  • Employed capillary depletion method, high-performance liquid chromatography (HPLC).
  • Utilized saturation experiments with unlabeled IL-1 alpha and radioactive labeling.

Main Results:

  • Radioactively labeled IL-1 alpha injected intravenously (iv) entered the CNS in intact form.
  • IL-1 alpha crossed the BBB into the brain cortex and CSF, areas lacking circumventricular organs or capillaries.
  • Capillary sequestration of IL-1 alpha occurred in a saturable manner, suggesting carrier-mediated transport.

Conclusions:

  • Circulating IL-1 alpha has direct access to the brain, including cortical cells, bypassing the BBB.
  • A saturable transport system facilitates IL-1 alpha entry into the CNS.
  • This pathway represents a significant route for brain-immune system interaction.